Desire for Substance Use Disorder Treatment Among HIV-infected Substance Users in Two U.S. Southern Cities
Methods: We used the baseline behavioral risk assessment from a randomized clinical trial evaluating the effectiveness of an integrated “Retention Clinic” in achieving virologic suppression among HIV-infected cocaine users. Multiple variable logistic regression was used to examine the relationship between desire for SUD treatment and perceived HIV stigma, medical mistrust and the ACI. Predictors are scaled to have a standard deviation of 1.
Results: Two-hundred-nineteen participants have been randomized into the trial; 60% are male, 82% are Black, and the mean age is 46. At baseline, all participants had a detectable viral load and reported substance use in the past year, 54.2% had moderate or greater substance use severity, and 41.3% had a desire for SUD treatment, which was associated with higher perceived HIV stigma (aOR 1.68, 95% CI (1.19, 2.36)), lower medical mistrust (aOR 0.61, 95% CI (0.43, 0.88)) and higher ACI (aOR 1.50, 95% CI (1.10, 2.05)).
Discussion: Perceived HIV stigma, medical mistrust and the ACI were associated with desire for SUD treatment. Although all participants self-reported substance use, less than half had a desire for SUD treatment. Further research should be conducted to assess the relationship between desire for and attendance at SUD treatment.
Learning Areas:Public health or related research
Social and behavioral sciences
Evaluate the association between the desire for substance use disorder treatment and perceived HIV stigma, medical mistrust and the Alcohol Composite Index from the Addiction Severity Index
Keyword(s): HIV/AIDS, Drug Abuse Treatment
Qualified on the content I am responsible for because: Over the past 6 years I have served as Project Coordinator or Director on several clinical trials involving: 1) HIV testing among individuals at risk for contracting HIV, 2) linking substance users to substance use disorder (SUD) treatment services, and 3) linking and retaining HIV-infected substance users to HIV care and SUD treatment. Additionally, I have been a co-author on several abstracts and manuscripts involving HIV and/or SUD treatment.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.